OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naïve chronic hepatitis B in South Korea
Seung Up Kim, Yeon Seok Seo, Han Ah Lee, et al.
Journal of Hepatology (2019) Vol. 71, Iss. 3, pp. 456-464
Closed Access | Times Cited: 156
Seung Up Kim, Yeon Seok Seo, Han Ah Lee, et al.
Journal of Hepatology (2019) Vol. 71, Iss. 3, pp. 456-464
Closed Access | Times Cited: 156
Showing 1-25 of 156 citing articles:
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Clinical and Molecular Hepatology (2022) Vol. 28, Iss. 4, pp. 583-705
Open Access | Times Cited: 195
Clinical and Molecular Hepatology (2022) Vol. 28, Iss. 4, pp. 583-705
Open Access | Times Cited: 195
Tenofovir Is Associated With Lower Risk of Hepatocellular Carcinoma Than Entecavir in Patients With Chronic HBV Infection in China
Terry Cheuk‐Fung Yip, Vincent Wai–Sun Wong, Henry Lik‐Yuen Chan, et al.
Gastroenterology (2019) Vol. 158, Iss. 1, pp. 215-225.e6
Closed Access | Times Cited: 189
Terry Cheuk‐Fung Yip, Vincent Wai–Sun Wong, Henry Lik‐Yuen Chan, et al.
Gastroenterology (2019) Vol. 158, Iss. 1, pp. 215-225.e6
Closed Access | Times Cited: 189
2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
Korean Journal of Radiology (2022) Vol. 23, Iss. 12, pp. 1126-1126
Open Access | Times Cited: 90
Korean Journal of Radiology (2022) Vol. 23, Iss. 12, pp. 1126-1126
Open Access | Times Cited: 90
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Journal of Liver Cancer (2022) Vol. 23, Iss. 1, pp. 1-120
Open Access | Times Cited: 83
Journal of Liver Cancer (2022) Vol. 23, Iss. 1, pp. 1-120
Open Access | Times Cited: 83
Comparison of tenofovir and entecavir on the risk of hepatocellular carcinoma and mortality in treatment-naïve patients with chronic hepatitis B in Korea: a large-scale, propensity score analysis
Sung Won Lee, Jung Hyun Kwon, Hae Lim Lee, et al.
Gut (2019) Vol. 69, Iss. 7, pp. 1301-1308
Open Access | Times Cited: 127
Sung Won Lee, Jung Hyun Kwon, Hae Lim Lee, et al.
Gut (2019) Vol. 69, Iss. 7, pp. 1301-1308
Open Access | Times Cited: 127
Tenofovir Versus Entecavir on Recurrence of Hepatitis B Virus–Related Hepatocellular Carcinoma After Surgical Resection
Jonggi Choi, Chanyoung Jo, Young‐Suk Lim
Hepatology (2020) Vol. 73, Iss. 2, pp. 661-673
Closed Access | Times Cited: 102
Jonggi Choi, Chanyoung Jo, Young‐Suk Lim
Hepatology (2020) Vol. 73, Iss. 2, pp. 661-673
Closed Access | Times Cited: 102
Hepatocellular carcinoma incidence with tenofovir versus entecavir in chronic hepatitis B: a systematic review and meta-analysis
Cheng‐Hao Tseng, Yao‐Chun Hsu, Tzu‐Haw Chen, et al.
The Lancet. Gastroenterology & hepatology (2020) Vol. 5, Iss. 12, pp. 1039-1052
Closed Access | Times Cited: 99
Cheng‐Hao Tseng, Yao‐Chun Hsu, Tzu‐Haw Chen, et al.
The Lancet. Gastroenterology & hepatology (2020) Vol. 5, Iss. 12, pp. 1039-1052
Closed Access | Times Cited: 99
An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B
Hwi Young Kim, Pietro Lampertico, Joon Yeul Nam, et al.
Journal of Hepatology (2021) Vol. 76, Iss. 2, pp. 311-318
Closed Access | Times Cited: 99
Hwi Young Kim, Pietro Lampertico, Joon Yeul Nam, et al.
Journal of Hepatology (2021) Vol. 76, Iss. 2, pp. 311-318
Closed Access | Times Cited: 99
Effects of Tenofovir vs Entecavir on Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection: A Systematic Review and Meta-analysis
Won‐Mook Choi, Jonggi Choi, Young‐Suk Lim
Clinical Gastroenterology and Hepatology (2020) Vol. 19, Iss. 2, pp. 246-258.e9
Closed Access | Times Cited: 97
Won‐Mook Choi, Jonggi Choi, Young‐Suk Lim
Clinical Gastroenterology and Hepatology (2020) Vol. 19, Iss. 2, pp. 246-258.e9
Closed Access | Times Cited: 97
Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B
Yao‐Chun Hsu, Grace Lai‐Hung Wong, Chien‐Hung Chen, et al.
The American Journal of Gastroenterology (2019) Vol. 115, Iss. 2, pp. 271-280
Closed Access | Times Cited: 91
Yao‐Chun Hsu, Grace Lai‐Hung Wong, Chien‐Hung Chen, et al.
The American Journal of Gastroenterology (2019) Vol. 115, Iss. 2, pp. 271-280
Closed Access | Times Cited: 91
Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop
Hyung Joon Yim, Ji Hoon Kim, Jun Yong Park, et al.
Clinical and Molecular Hepatology (2020) Vol. 26, Iss. 4, pp. 411-429
Open Access | Times Cited: 85
Hyung Joon Yim, Ji Hoon Kim, Jun Yong Park, et al.
Clinical and Molecular Hepatology (2020) Vol. 26, Iss. 4, pp. 411-429
Open Access | Times Cited: 85
Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B
George Papatheodoridis, George Ν. Dalekos, Ramazan İdilman, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 5, pp. 1037-1045
Closed Access | Times Cited: 84
George Papatheodoridis, George Ν. Dalekos, Ramazan İdilman, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 5, pp. 1037-1045
Closed Access | Times Cited: 84
Comparative Effectiveness of Entecavir Versus Tenofovir for Preventing Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: A Systematic Review and Meta‐Analysis
Shravan Dave, Soo‐Young Park, M. Hassan Murad, et al.
Hepatology (2020) Vol. 73, Iss. 1, pp. 68-78
Open Access | Times Cited: 77
Shravan Dave, Soo‐Young Park, M. Hassan Murad, et al.
Hepatology (2020) Vol. 73, Iss. 1, pp. 68-78
Open Access | Times Cited: 77
Impact of preoperative antiviral therapy on the prognosis of hepatitis B virus-related hepatocellular carcinoma
Yuxin Liang, Deyuan Zhong, Zilong Zhang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 11
Yuxin Liang, Deyuan Zhong, Zilong Zhang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 11
Risk of HBV reactivation in patients with immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma
Pei‐Chang Lee, Yee Chao, Ming‐Huang Chen, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e001072-e001072
Open Access | Times Cited: 67
Pei‐Chang Lee, Yee Chao, Ming‐Huang Chen, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e001072-e001072
Open Access | Times Cited: 67
Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir Treatment for Chronic Hepatitis B Virus
Darren Jun Hao Tan, Cheng Han Ng, Phoebe Wen Lin Tay, et al.
JAMA Network Open (2022) Vol. 5, Iss. 6, pp. e2219407-e2219407
Open Access | Times Cited: 34
Darren Jun Hao Tan, Cheng Han Ng, Phoebe Wen Lin Tay, et al.
JAMA Network Open (2022) Vol. 5, Iss. 6, pp. e2219407-e2219407
Open Access | Times Cited: 34
Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in treatment‐naïve chronic hepatitis B
Jihye Lim, Won‐Mook Choi, Ju Hyun Shim, et al.
Liver International (2022) Vol. 42, Iss. 7, pp. 1517-1527
Closed Access | Times Cited: 30
Jihye Lim, Won‐Mook Choi, Ju Hyun Shim, et al.
Liver International (2022) Vol. 42, Iss. 7, pp. 1517-1527
Closed Access | Times Cited: 30
Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysis
Zehong Huang, Guiyang Lu, Lingxian Qiu, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 29
Zehong Huang, Guiyang Lu, Lingxian Qiu, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 29
Hepatitis B Virus Treatment and Hepatocellular Carcinoma: Controversies and Approaches to Consensus
Soo Ki Kim, Takako Fujii, Soo Ryang Kim, et al.
Liver Cancer (2022) Vol. 11, Iss. 6, pp. 497-510
Open Access | Times Cited: 29
Soo Ki Kim, Takako Fujii, Soo Ryang Kim, et al.
Liver Cancer (2022) Vol. 11, Iss. 6, pp. 497-510
Open Access | Times Cited: 29
Tenofovir versus entecavir in lowering the risk of hepatocellular carcinoma development in patients with chronic hepatitis B: a critical systematic review and meta-analysis
Min� Li, Tingting Lv, Shanshan Wu, et al.
Hepatology International (2020) Vol. 14, Iss. 1, pp. 105-114
Closed Access | Times Cited: 40
Min� Li, Tingting Lv, Shanshan Wu, et al.
Hepatology International (2020) Vol. 14, Iss. 1, pp. 105-114
Closed Access | Times Cited: 40
No difference in hepatocellular carcinoma risk between chronic hepatitis B patients treated with entecavir versus tenofovir
Feng Su, Kristin Berry, George N. Ioannou
Gut (2020), pp. gutjnl-319867
Closed Access | Times Cited: 40
Feng Su, Kristin Berry, George N. Ioannou
Gut (2020), pp. gutjnl-319867
Closed Access | Times Cited: 40
Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma
Sung Won Lee, Jonggi Choi, Seung Up Kim, et al.
Clinical and Molecular Hepatology (2021) Vol. 27, Iss. 3, pp. 402-412
Open Access | Times Cited: 36
Sung Won Lee, Jonggi Choi, Seung Up Kim, et al.
Clinical and Molecular Hepatology (2021) Vol. 27, Iss. 3, pp. 402-412
Open Access | Times Cited: 36
Long-term efficacy and safety of nucleos(t)ides analogues in patients with chronic hepatitis B
Luisa Roade, Mar Riveiro‐Barciela, Rafael Esteban, et al.
Therapeutic Advances in Infectious Disease (2021) Vol. 8, pp. 204993612098595-204993612098595
Open Access | Times Cited: 35
Luisa Roade, Mar Riveiro‐Barciela, Rafael Esteban, et al.
Therapeutic Advances in Infectious Disease (2021) Vol. 8, pp. 204993612098595-204993612098595
Open Access | Times Cited: 35
Lower risk of hepatocellular carcinoma with tenofovir than entecavir treatment in subsets of chronic hepatitis B patients: an updated meta‐analysis
Bao‐Hong Yuan, Ru‐Hong Li, Rong‐Rui Huo, et al.
Journal of Gastroenterology and Hepatology (2022) Vol. 37, Iss. 5, pp. 782-794
Open Access | Times Cited: 26
Bao‐Hong Yuan, Ru‐Hong Li, Rong‐Rui Huo, et al.
Journal of Gastroenterology and Hepatology (2022) Vol. 37, Iss. 5, pp. 782-794
Open Access | Times Cited: 26
Tenofovir vs. entecavir on prognosis of hepatitis B virus-related hepatocellular carcinoma after curative resection
Xiaohui Wang, Zili Hu, Yizhen Fu, et al.
Journal of Gastroenterology (2022) Vol. 57, Iss. 3, pp. 185-198
Closed Access | Times Cited: 25
Xiaohui Wang, Zili Hu, Yizhen Fu, et al.
Journal of Gastroenterology (2022) Vol. 57, Iss. 3, pp. 185-198
Closed Access | Times Cited: 25
